Altre lingue JCR Pharmaceuticals Co., Ltd.

Azioni

4552

JP3701000006

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 02/05/2024			Variaz. 5gg	Var. 1 gen.
806 ^JPY	-0,86%		+1,13%	-31,23%

25/04	JCR Pharmaceuticals Co., Ltd. annuncia cambiamenti nel management, con effetto dal 26 giugno 2024	CI
21/03	Le previsioni sui tassi della Fed statunitense catapultano le azioni giapponesi a un nuovo picco di 52 settimane	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024	25/04
US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	21/03
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion	21/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	20/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index	18/03
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13/03
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community	29/02
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes	28/02
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders	15/02
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders	14/02
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier	14/02
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024	25/01
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration	21/12
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology	21/12
Asia Markets Remain Mixed as Investors Step Back Following Rally	21/12
Japanese Shares Slip Back into Red as Wall Street Ends Winning Streak Ahead of Key US Data	21/12
JCR Pharmaceuticals' Partner Takeda to Scrap Gene Therapy Collaboration	21/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue JCR Pharmaceuticals Co., Ltd.

Azioni

4552

JP3701000006

Altre lingue

Filtri